iShares U.S. Consumer Staples ETF news

IYK is recommended as the better buy due to lower expense ratio (0.38%), significantly larger AUM ($1.4B) providing better liquidity, superior 5-year returns, lower maximum drawdown (15% vs 21.7%), and broader diversification across 53 holdings in consumer staples, healthcare, and basic materials.

Superior performance across all metrics including lower expense ratio (0.38%), higher dividend yield (2.6%), better 1-year returns (8.9%), broader diversification with 53 holdings, and significantly larger AUM ($1.4B). Recommended as the better choice for investors seeking stability and income.

IYK is presented as a viable alternative for specific investor preferences (higher dividend yield of 2.5%, healthcare and basic materials diversification), but is disadvantaged by a higher expense ratio (0.38%) and weaker historical performance compared to FSTA.

IYK demonstrates superior performance with 8.8% annualized returns since 2000, lower expense ratio (0.38%), higher 5-year growth ($1,364 vs $955), smaller maximum drawdown (15.10% vs 21.70%), and broader diversification across consumer staples sector with 54 holdings.

IYK is presented as a viable alternative with some advantages (broader diversification, lower volatility, more holdings) but significant drawbacks (much higher expense ratio at 0.38%, underperformance vs XLP, smaller fund size). The comparison is balanced rather than favorable.

IYK is presented as a viable alternative with advantages in dividend yield (2.4%) and lower maximum drawdown (-15.05%), plus broader sector diversification including healthcare. However, it is disadvantaged by a much higher expense ratio (0.38%) and lower recent returns, making it suitable only for specific investor preferences.